Oxidative degradation products of atorvastatin calcium
Details for Australian Patent Application No. 2005263550 (hide)
International Classifications
Event Publications
4 January 2007 PCT application entered the National Phase
PCT publication WO2006/008091 Priority application(s): WO2006/008091
3 November 2011 Application Accepted
Published as AU-B-2005263550
27 September 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 17 Apr 2012 . Address for service in Australia - Griffith Hack GPO Box 3125 Brisbane QLD 4001
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005263551-Use of a steroid for enhancement of skin permeability
2005263526-Indolone derivatives, processes for preparing them and their uses
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser